Home/Filings/4/0001742496-25-000010
4//SEC Filing

Moss Gregory S. 4

Accession 0001742496-25-000010

CIK 0002044725other

Filed

Nov 11, 7:00 PM ET

Accepted

Nov 12, 4:20 PM ET

Size

8.0 KB

Accession

0001742496-25-000010

Insider Transaction Report

Form 4
Period: 2025-11-07
Moss Gregory S.
Chief Business & Legal Officer
Transactions
  • Conversion

    Common Stock

    2025-11-07+3,1753,175 total(indirect: By Trust)
  • Conversion

    Series B Preferred Stock

    2025-11-0725,0000 total(indirect: By Trust)
    Common Stock (3,175 underlying)
Holdings
  • Common Stock

    74,459
Footnotes (2)
  • [F1]Each share of Series B Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering for no additional consideration on a 1-for-7.8721 basis and had no expiration date.
  • [F2]The securities are held by a family trust, of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his proportionate pecuniary interest therein.

Issuer

Evommune, Inc.

CIK 0002044725

Entity typeother

Related Parties

1
  • filerCIK 0001742496

Filing Metadata

Form type
4
Filed
Nov 11, 7:00 PM ET
Accepted
Nov 12, 4:20 PM ET
Size
8.0 KB